How Things Will Change Due to COVID-19 - Research Perspective - Marta Boffito, MD, PhD, FRCP

International Workshop on Innovations in Delivery of HIV Care 2021

Oral Antivirals for COVID-19: Drug-Drug Interactions as a Manageable Risk - David Burger, PharmD, PhD

Course on Clinical Pharmacology of SARS-CoV-2 Antivirals 2022

Monoclonal Antibodies for Prevention of HIV, COVID, and Ebola - Dr, Cohen

International Workshop on Monoclonal Antibodies for HIV, COVID-19, and Oncology 2021

Update on Prevention and Treatment of COVID-19 in Immunocompromised Populations | Jonathan Li, MD

COVID-19 Clinical Forum 2022

Clinical Management of COVID-19 in High-risk Populations | Claudia Cortes, MD

Approaches to Combat COVID-19 in Low- and Middle-Income Countries Workshop 2022

Update on COVID-19 Therapeutics (September 2022 Edition) | D. Kuritzkes, MD

COVID-19 Clinical Forum 2022

Update on COVID-19 Therapeutics (May 2022 Edition) | Daniel Kuritzkes, MD

COVID-19 Clinical Forum 2022

Update on COVID-19 Therapeutics (March 2022 Edition) | Daniel Kuritzkes, MD

COVID-19 Clinical Forum 2022

The Impact of COVID-19 on Global Health Burden - Christian Brechot, MD, PhD

Approaches to Combat COVID-19 in Low- and Middle-Income Countries Workshop

COVID-19 Therapeutics: State-Of-The-Art - Daniel Kuritzkes, MD

COVID-19 Clinical Management Workshop 2021